|
MKV: Results of Annual General Meeting of Shareholders 2010
Cai Lay Veterinary Pharmaceutical JSC has disclosed the results of its Annual General Meeting of Shareholders held on 17/04/2010. The following resolutions were approved:
1. Result of 2009
* Gross sale of merchandise: VND 28,327,828,285
* Profit before tax: VND 1,758,061,641
2. 2009 Plan of Profit distribution
* Accounting profite before tax: VND 1,758,061,641
* Profit after tax: VND 1,594,183,069
* Dividend payment (12% Charter Capital, 6% in cash and 6% by shares): VND 1,200,000,000
* Fund of Investment and Development (13.73% profit after tax): VND 202,881,101
* Fund of Financial reserve (5% profit after tax): VND 79,709,153
* Fund of Welfare and Reward (7% profit after tax): VND 111,592,815
3. Audited financial statement of 2009
4. Plan of 2010
* Gross sale of merchandise: VND 36,000,000,000
* Profit before tax: VND 1,800,000,000
* Average number of employees (Persons): 100
* Salary fund (8.17% revenue; 63.36% non-salary profit): VND 2,940,000,000
* Payment for General Manager (% non-salary profit): 2.5 – 3.5
* Payment for BOD and Supervisory of the Board (0.38% revenue): VND 136,200,000
* Capital and capital source
+ Charter Capital: VND 10,600,000,000
+ Capital requirement: VND 36,000,000,000
+ Capital turnover: round/year 3
+Necessary capital requirement: VND 12,000,000,000
* Profit after tax: VND 1,440,000,000
* Dividend payment (12%, 6% in cash and 6% by shares): VND 1,272,000,000
* Funds: VND 168,000,000
5. Allowing Chair of the Board – cum – General Manager
6. Assigning BOD to choose audit company for 2010
7. Assigning BOD to establish a manufacture of veterinary medicine which meets GMP standard
8. Plan of additional issue to increase Charter Capital from VND bil. 10 to VND bil. 15
* Purpose: increasing capital to invest into the Manufacture of veterinary medicine
* Volume: 500,000 shares
* Price per share: VND 10,000
* Value of additional issue: VND 5,000,000,000
* Charter Capital after issuing: VND 15,000,000,000
* Method of issue: assigned BOD to choose
* Expected date of issue: QIII/2010.
hnx
|
